Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;1(1):28-34.
doi: 10.4021/wjon2010.02.191w. Epub 2010 Feb 1.

Results of Treatment of Squamous Cell Carcinoma of Maxillary Sinus: A 26-Year Experience

Affiliations

Results of Treatment of Squamous Cell Carcinoma of Maxillary Sinus: A 26-Year Experience

M Ashraf et al. World J Oncol. 2010 Feb.

Abstract

Background: Five-year survival in squamous cell carcinoma of maxillary antrum is low. This article examines the results of various approaches to treatment as given in our hospital in past 26 years.

Methods: From 1979 to 2005, 379 patients with squamous cell carcinoma of maxillary antrum managed with curative intent were studied. Twenty-eight patients had T2, 237 patients had T3, and 114 had T4 tumors. The N classification was N0 in 316 patients, N1 in 21 patients, N2a in 28 patients and N2b in 14 patients. Treatment to the primary site comprised of surgery (Sx) and radiation therapy (RT) in 284 patients, RT alone in 57 patients and chemotherapy (CTx) with radiotherapy in 38 patients.

Results: There was a difference in survival between patients who underwent Sx with RT compared with patients who received RT alone or CTx with RT. The most common pattern of recurrence was in the primary site, 187 (49.3%) patients. Local control at 3 and 5 years was 71% and 63.8% respectively in Sx with RT, 31.6% and 28% respectively in RT, and 28.9% and 26% in CTx with RT group.

Conclusions: The type of treatment to the primary site is an important determinant of survival and local control. Surgery with radiation is a better treatment option.

Keywords: Antrum; Maxillary; Second primary; Squamous.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest.

References

    1. Nunez F, Suarez C, Alvarez I, Losa JL, Barthe P, Fresno M. Sino-nasal adenocarcinoma: epidemiological and clinico-pathological study of 34 cases. J Otolaryngol. 1993;22(2):86–90. - PubMed
    1. Paulino AC, Marks JE, Bricker P, Melian E, Reddy SP, Emami B. Results of treatment of patients with maxillary sinus carcinoma. Cancer. 1998;83(3):457–465. doi: 10.1002/(SICI)1097-0142(19980801)83:3<457::AID-CNCR14>3.0.CO;2-V. - DOI - PubMed
    1. Sakai S, Hohki A, Fuchihata H, Tanaka Y. Multidisciplinary treatment of maxillary sinus carcinoma. Cancer. 1983;52(8):1360–1364. doi: 10.1002/1097-0142(19831015)52:8<1360::AID-CNCR2820520804>3.0.CO;2-%2523. - DOI - PubMed
    1. Rifki N. Problems of paranasal sinus malignancy in Indonesia. ORL Indonesia. 1985;16:175–180.
    1. Sharma S, Sharma SC, Singhal S. et al. Carcinoma of the Maxillary antrum. A 10-year experience. Ind J Otolaryngol. 1991;43:191–194.

LinkOut - more resources